Business Wire

Verimatrix Launches XTD Velocity Partner Alliance to Accelerate Global Channel Sales

19.3.2025 17:45:00 CET | Business Wire | Press release

Share

Risk Associates, a Middle East leader, joins the partner program to drive Verimatrix XTD app protection, threat detection & Response managed services to their customers

Regulatory News:

Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced the launch of the Verimatrix XTD Velocity Partner Alliance, a global channel sales program designed to empower partners with best-in-class application protection solutions. As part of this initiative, Risk Associates, a leading Managed Security Services Provider (MSSP), has joined the program to offer Verimatrix XTD Enterprise Suite to banks and enterprises across Australia, Bahrain, Saudi Arabia, and the UAE.

The XTD Velocity Partner Alliance, spearheaded by Simon Emery, Global Head of Strategic Partnerships at Verimatrix, provides resellers, MSSPs, system integrators, and cybersecurity firms with comprehensive resources to deliver AI-powered mobile app shielding, endpoint threat detection, and response solutions. The program enhances channel sales by offering:

  • Resell XTD & Deliver Managed Services – Offer 24/7 app hardening with AI-driven threat detection to stop cyberattacks.
  • Expert Training & Certification – Gain the skills to deploy and integrate Verimatrix XTD with confidence.
  • Marketing & Sales Power – Access co-branded campaigns, deal registration, and exclusive marketing funds.
  • Innovate & Collaborate – Partner on cutting-edge security solutions through joint development and certification.

“With the Verimatrix XTD Velocity Partner Alliance, we're redefining how cybersecurity providers and channel partners collaborate to accelerate app protection at scale,” said Jon Samsel, Global Head of Cybersecurity Business at Verimatrix. “Our expanded partnership with Risk Associates has already resulted in six banks choosing Verimatrix to safeguard their applications—and we’re just getting started. Strategic alliances like this ensure that financial institutions can leverage our award-winning technologies to protect their app code, customer data, and brand reputation with confidence.”

Having successfully deployed Verimatrix XTD app protection for fintech and banking institutions since last year, Risk Associates brings over 20 years of cybersecurity expertise and serves as a trusted MSSP for top brands and startups across the region.

It’s dedication to shielding businesses from the latest threats, including mobile-based attacks, matches well with the opportunity to offer its customers the Verimatrix XTD suite that powerfully protects mobile app owners from reverse engineering, application repackaging attacks, dynamic modification, man-in-the-device attacks while also providing anti-Frida, anti-emulator and anti-debugger defenses.

“Risk Associates welcomes this partnership with Verimatrix to offer proven protections for vital mobile apps that are relied upon by millions in the regions we serve,” said Aziz A. Rahim, Chief Operating Officer at Risk Associates. “Verimatrix’s powerful yet easily-to-implement XTD technologies provide tremendous value to customers through extensive threat visibility and remediation that is often lacking in vulnerable apps that remain crucial for enterprises and their users.”

As part of the XTD Velocity Partner Alliance, Risk Associates now offers the following Verimatrix XTD platform solutions:

Verimatrix XTD Enterprise includes:

  • XTD Protect for iOS
  • XTD Protect for Android
  • XTD Detection & Response

Additional Verimatrix solutions available for resale include:

  • XTD Protect for Desktop/Embedded
  • XTD Protect for Web
  • XTD Protect Native for iOS
  • XTD Protect Native for Android
  • XTD Managed Services

For more information on joining the Verimatrix XTD Velocity Partner Alliance, visit https://www.verimatrix.com/partners.

About Risk Associates
At Risk Associates, our passion is simplifying compliance for organizations in an increasingly complex regulatory environment. As a UKAS-accredited certification body, we specialize in offering certifications and assessments that enable businesses to meet international standards, minimize risks, and safeguard their operations. We take pride in our role as PCI GEAR (Global Executive Assessor Roundtable) Advisors, ranking among the top 30 QSA companies globally.

Risk Associate’s industry recognition, encompassing PCI DSS, PCI PIN, PCI P2PE, PCI TSP, PCI SSF, PCI SSLC, PCI ASV, PCI 3DS, CSA STAR, SOC I and II, ISO/IEC 27001, ISO/IEC 27701, ISO/IEC 22301, ISO/IEC 20000, HIPAA, HITRUST, GDPR, SWIFT, MARS-E, and NIST, serves as a testament to our expertise, knowledge and compliance competence. As a Qualified Security Assessor (PCI-QSA) company approved by the Payment Card Industry (PCI) Security Standards Council, we are acknowledged as an industry leader specializing in cybersecurity, compliance, information governance, strategy and training. Our services extend across Australia, Europe, the Middle East, Asia Pacific and North America. Visit www.riskassociates.com. Visit www.riskassociates.com.

About Verimatrix
Verimatrix (Euronext Paris: VMX, FR0010291245) helps power the modern connected world with security made for people. We protect digital content, applications, and devices with intuitive, people-centered and frictionless security. Leading brands turn to Verimatrix to secure premium movies, live streaming sports, sensitive financial and healthcare data, mission-critical mobile applications, and much more. We enable the trusted connections our customers depend on to deliver compelling content and experiences to millions of consumers around the world. Verimatrix helps partners get to market faster, scale easily, protect valuable revenue streams, and win new business. Visit www.verimatrix.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250319818660/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 07:30:00 CET | Press release

Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob

Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 06:30:00 CET | Press release

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan

VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 01:00:00 CET | Press release

Enabling Next-Generation High-Performance Automotive Camera Systems VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise

Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 22:30:00 CET | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 22:30:00 CET | Press release

Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye